Indefinite Delivery Contract SPE2DB22D9172
Award Date
3/7/23
Last Date to Order
12/24/25
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency awarded a single-award indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies. The contract has a potential value of $499,999,999 and period of performance through December 31, 2025. Under the contract, DMS Pharmaceutical Group Inc. received ten delivery orders for pharmaceuticals and medical supplies valued between $3-$409 to be delivered to locations in Park Ridge, Illinois by various dates in 2023. The...
The Defense Logistics Agency awarded a single-award indefinite delivery contract to DMS Pharmaceutical Group Inc. to serve as a prime vendor for pharmaceutical products under contract number 4600080980. The contract has a potential value of $4,999,999 and period of performance through December 2025. DMS Pharmaceutical Group Inc. has been issued multiple delivery orders against the contract to supply various pharmaceuticals to the Defense Logistics Agency from its place of performance in Park...
DMS Pharmaceutical Group Inc. has been awarded an indefinite delivery contract by the Defense Logistics Agency to provide pharmaceutical supplies and medical products. The contract has a potential value of up to $5 million and a period of performance through December 2025. Under the contract, DMS Pharmaceutical Group will supply various pharmaceutical items and medical supplies to support military treatment facilities worldwide. Some of the key products to be delivered include atropine,...
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. as the prime contractor. The contract functions as a blanket purchase agreement for the Agency to issue delivery orders on an as-needed basis for pharmaceutical products and medical supplies in support of Department of Defense force health protection programs. Delivery orders provided under the contract call for DMS Pharmaceutical to supply various vaccines, contraceptive devices, antibiotics,...
The Defense Logistics Agency has awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a variety of pharmaceutical and medical supplies. The single-award contract has a potential value of up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will deliver pharmaceutical items such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine...
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products in support of Department of Defense programs. The contract has a potential value of $499,999,999 and a period of performance through December 2025. Task orders issued by the Defense Logistics Agency against this contract include delivery of various prescription medications to locations in Park Ridge, Illinois, including cystic fibrosis drugs...
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies in support of Department of Defense programs. The IDV has a potential value of $499,999,999 and period of performance through December 2025. Task orders issued against the contract include delivery of contraceptive implants, vaccines, injectable and topical medications, and other pharmaceutical products. DMS Pharmaceutical will provide...
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies on an as-needed basis. The contract has a potential value of $499,999,999 and a period of performance through December 31, 2025. Task orders issued against the contract by DLA between January 18, 2023 and August 30, 2022 require DMS Pharmaceutical to deliver a variety of pharmaceutical products to locations in Park Ridge, Illinois. These...
The Defense Logistics Agency awarded a single award indefinite delivery contract to DMS Pharmaceutical Group Inc. with a potential value of $499,999,999 to serve as a prime vendor for pharmaceutical products and services. The contract has a period of performance through December 2025. Under the contract, DMS Pharmaceutical Group will supply pharmaceuticals to military treatment facilities from its distribution center in Philadelphia, Pennsylvania on an as-needed basis. One such order awarded...